These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3270968)

  • 1. The acceptable face of international competition. Stereophobia: an economic afterthought.
    Ariëns EJ
    Trends Pharmacol Sci; 1988 Sep; 9(9):317. PubMed ID: 3270968
    [No Abstract]   [Full Text] [Related]  

  • 2. Inspections: the international regulatory view--Japan.
    Kamura S
    PDA J Pharm Sci Technol; 1994; 48(4):182-3. PubMed ID: 7804816
    [No Abstract]   [Full Text] [Related]  

  • 3. Harmonization, regulation, and trade: where do we go from here?
    Horton LR
    PDA J Pharm Sci Technol; 1996; 50(1):61-5. PubMed ID: 8846062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Regulation and Pricing--Can Regulators Influence Affordability?
    Eichler HG; Hurts H; Broich K; Rasi G
    N Engl J Med; 2016 May; 374(19):1807-9. PubMed ID: 27168431
    [No Abstract]   [Full Text] [Related]  

  • 5. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 6. The default of 1998 and pharmaceutical market. Report I. The chronicle of disaster.
    Zatravkin SN; Ignatiev VG; Vishlenkova EA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 Jul; 30(4):683-691. PubMed ID: 35960302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 8. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 9. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Accession to the PIC/S and pharmaceutical quality system in Japan].
    Katori N
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 12. China's deadly drug problem.
    Cyranoski D
    Nature; 2007 Apr; 446(7136):598-9. PubMed ID: 17410150
    [No Abstract]   [Full Text] [Related]  

  • 13. Global health-care implications of substandard medicines.
    Senior K
    Lancet Infect Dis; 2008 Nov; 8(11):666. PubMed ID: 18992395
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standards of acceptable manufacturing and inspection methods].
    Battaglino G
    Boll Chim Farm; 1984 Jun; 123(6):247-62. PubMed ID: 6497974
    [No Abstract]   [Full Text] [Related]  

  • 15. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of gatt agreement on drug prices.
    Pillai AM
    J Indian Med Assoc; 1995 Mar; 93(3):113, 120. PubMed ID: 8522810
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Objectives and organization of the International Conference on Harmonization].
    Juillet Y
    Ann Pharm Fr; 1999 Mar; 57(2):137-42. PubMed ID: 10365469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDA comments: PIC-S active pharmaceutical ingredients. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1998; 52(5):234-5. PubMed ID: 9846072
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug recalls as viewed by the manufacturer.
    Mitchell CM
    J Am Pharm Assoc; 1967 Nov; 7(11):575-7. PubMed ID: 6063674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.